NCT05501938

Brief Summary

RCT assessing preterm delivery rate in singleton pregnancies having a physical-exam indicated cerclage placed between 24 weeks and 25 weeks and 6 days. Patients randomized to either cerclage intervention or routine standard of care (no cerclage).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 11, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

August 11, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 16, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 11, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 11, 2023

Completed
Last Updated

August 16, 2022

Status Verified

August 1, 2022

Enrollment Period

1 year

First QC Date

August 11, 2022

Last Update Submit

August 12, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Preterm Delivery Rate

    Compare preterm delivery rate between women receiving cerclage intervention between 24w0d and 25w6d vs those not receiving cerclage during this gestational age period

    1 Year

Secondary Outcomes (1)

  • Neonatal Outcomes

    1 Year

Other Outcomes (1)

  • Cerclage Surgical Complications

    1 year

Study Arms (2)

Cerclage

EXPERIMENTAL

Perform physical exam indicated cerclage between 24w0d to 25w6d

Procedure: Physical Exam Indicated Cerclage

Control

NO INTERVENTION

No intervention; routine monitoring in pregnancy for preterm delivery

Interventions

Transvaginal cervical cerclage

Cerclage

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pregnant women 18 years of age or older
  • Nulliparous patient, has not had a preterm to term delivery
  • Singleton pregnancy
  • English or Spanish speaking
  • Asymptomatic cervical dilation between 1- 2 cm, without visible membranes beyond the external cervical os and without any evidence of infection, active labor or active bleeding between 24 0/7 and 25 6/7 weeks gestation

You may not qualify if:

  • Twin or higher order multi-fetal gestation
  • Multiparous patient, has had one or more preterm to term deliveries
  • Cervical dilation more than 2 cm either at the beginning of the study or any time during the study
  • Amniotic membranes prolapsed beyond the external os
  • Fetal reduction procedure performed during current pregnancy
  • Ruptured membranes prior to randomization
  • Major fetal structural anomaly
  • Fetal chromosomal abnormality, suspected or confirmed with additional genetic testing
  • Cerclage already in place for other indication
  • Active vaginal bleeding
  • Suspicion of chorioamnionitis
  • Placenta previa
  • Painful regular uterine contractions
  • History of preterm birth before 37 weeks gestation
  • Non-English or non-Spanish speaking
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Albany Medical Center

Albany, New York, 12208, United States

RECRUITING

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Central Study Contacts

Craig Zelig, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Intervention (cerclage) and control (no-cerclage) to reduce/prevent preterm delivery in those with a dilated cervix between 24w0d and 25w6d
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Maternal Fetal Medicine; MFM Fellowship Director

Study Record Dates

First Submitted

August 11, 2022

First Posted

August 16, 2022

Study Start

August 11, 2022

Primary Completion

August 11, 2023

Study Completion

August 11, 2023

Last Updated

August 16, 2022

Record last verified: 2022-08

Locations